Anika Therapeutics Inc. Stock News

InMode went public in August, 2019, raising $70 million. The firm sells medical aesthetic technologies in the U.S.

Most readers would already be aware that Anika Therapeutics' (NASDAQ:ANIK) stock increased significantly by 16% over...

Anika Therapeutics' (NASDAQ:ANIK) stock is up by a considerable 16% over the past three months. However, we decided to...

The Global Osteoarthritis Therapeutics Market will grow by USD 2.99 bn during 2020-2024

Seasoned financial executive brings broad medical device industry experience and track record of value creationBEDFORD, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK

ANIK vs. ALKS: Which Stock Is the Better Value Option?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q2 2020 Earnings Conference Call July 30, 2020 5:00 PM ET Company Participants Kristen Galfetti - Investor Relations Cheryl Blanchard - President and Chief Execu

Anika is an exciting play in the orthopedic space. The company provides joint preservation, regenerative therapies and sports medicine.

The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2020 Q2 earnings call..

With me today on the call is Dr. Cheryl Blanchard, President and Chief Executive Officer; and Sylvia Cheung, Chief Financial Officer of Anika. During today's call, Cheryl and Sylvia will review Anika

Anika (ANIK) delivered earnings and revenue surprises of 142.86% and 83.37%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Increased Total Revenue 1% Year-over-Year to $30.7 Million Accelerated the Commercial Integration of Parcus Medical and Arthrosurface Organizations Launching Seven FDA-Cleared Orthopedic and Sports

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) Abbott Laboratories (NYSE: ABT) ABIOMED, Inc. (NASDAQ: ABMD) Adamis Pharmaceuticals Corp (NASDAQ: ADMP) Annexon...

Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks. Although there were promising updates from...